Geoffrey M. Parker, CHIEF FINANCIAL OFFICER at Allogene Therapeutics, Inc. (ALLO), bought 190 shares at $3.60 ($684) on 2024-01-30, disclosed to the SEC on 2024-03-06.
Open-market purchase of $684 ALLO by CHIEF FINANCIAL OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ALLO | SELL | 2025-10-23 | $46K | — | Filing → |
| PRGO | BUY | 2025-08-20 | $201K | — | Filing → |
| PRGO | BUY | 2025-05-14 | $95K | — | Filing → |